Mazdutide has demonstrated excellent weight loss and glucose-lowering effects in clinical studies, as well as reducing waist circumference, blood lipids, blood pressure, serum uric acid, liver enzymes, liver fat content and improved insulin sensitivity
doi: 10.3389/fpsyt.2025.1555370 Received 06 January 2025 Accepted 25 July 2025 Published 19 August 2025 Volume 16 - 2025 Edited by Veena Kumari, Brunel University London, United Kingdom Reviewed by Krupa Vakani, Imperial College, United Kingdom Updates Copyright 2025 Shen, Zhao, Pei, Wang, Hou, Chai, Guo, Li, Hao and Wu
Key Takeaways GLP-1 medicines mimic a natural gut hormone Most current options are injectable Oral GLP-1 medicines are emerging as a major advancement Newer oral options aim to improve ease and adherence Treatment choice depends on individual health needs GLP-1 medicines are changing how diabetes and obesity are managed
How long does a semaglutide injection lump usually last